A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System

Circulating tumor cells (CTCs) captured from the blood of cancer patients may serve as a surrogate source of tumor material that can be obtained via a venipuncture (also known as a liquid biopsy) and used to better understand tumor characteristics. However, the only FDA-cleared CTC assay has been li...

Full description

Bibliographic Details
Main Authors: Evan N. Cohen, Gitanjali Jayachandran, Richard G. Moore, Massimo Cristofanilli, Julie E. Lang, Joseph D. Khoury, Michael F. Press, Kyu Kwang Kim, Negar Khazan, Qiang Zhang, Youbin Zhang, Pushpinder Kaur, Roberta Guzman, Michael C. Miller, James M. Reuben, Naoto T. Ueno
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
circulating tumor cells
neoplastic cells
circulating
neoplasms/diagnosis
circulating/pathology
biopsy
Online Access:https://www.mdpi.com/2072-6694/14/21/5238

Internet

https://www.mdpi.com/2072-6694/14/21/5238

Similar Items